Biopolymeric nanocarriers in cancer therapy: unleashing the potency of bioactive anticancer compounds for enhancing drug delivery

被引:1
|
作者
Hadkar, Vrushali Manoj [1 ]
Mohanty, Chirasmita [1 ]
Selvaraj, Chinnadurai Immanuel [2 ]
机构
[1] Vellore Inst Technol VIT, Sch Biosci & Technol, Vellore 632014, Tamil Nadu, India
[2] VIT, VIT Sch Agr Sci & Adv Learning VAIAL, Dept Genet & Plant Breeding, Vellore 632014, Tamil Nadu, India
关键词
CELLS IN-VITRO; NATURAL-PRODUCTS; CHITOSAN NANOPARTICLES; SECONDARY METABOLITES; CASEIN NANOPARTICLES; ANTITUMOR-ACTIVITY; DOWN-REGULATION; CARRIER SYSTEM; OVARIAN-CANCER; ORAL DELIVERY;
D O I
10.1039/d4ra03911d
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Effective cancer treatment is becoming a global concern, and recent developments in nanomedicine are essential for its treatment. Cancer is a severe metabolic syndrome that affects the human population and is a significant contributing factor to deaths globally. In science, nanotechnology offers rapidly developing delivery methods for natural bioactive compounds that are becoming increasingly prominent and can be used to treat diseases in a site-specific way. Chemotherapy and radiotherapy are conventional approaches for preventing cancer progression and have adverse effects on the human body. Many chemically synthesized drugs are used as anticancer agents, but they have several side effects; hence, they are less preferred. Medicinal plants and marine microorganisms represent a vast, mostly untapped reservoir of bioactive compounds for cancer treatment. However, they have several limitations, including nonspecific targeting, weak water solubility and limited therapeutic potential. An alternative option is the use of biopolymeric nanocarriers, which can generate effective targeted treatment therapies when conjugated with natural anticancer compounds. The present review focuses on biopolymeric nanocarriers utilizing natural sources as anticancer drugs with improved tumor-targeting efficiency. This review also covers various natural anticancer compounds, the advantages and disadvantages of natural and synthetic anticancer compounds, the problems associated with natural anticancer drugs and the advantages of biopolymeric nanocarriers over synthetic nanocarriers as drug delivery agents. This review also discusses various biopolymeric nanocarriers for enhancing the controlled delivery of anticancer compounds and the future development of nanomedicines for treating cancer. Effective cancer treatment is becoming a global concern, and recent developments in nanomedicine are essential for its treatment.
引用
收藏
页码:25149 / 25173
页数:25
相关论文
共 50 条
  • [41] StarPEG Nanocarriers for Prostate Cancer Imaging and Drug Delivery
    Meher, Niranjan
    Ashley, Gary
    Bidkar, Anil
    Wadhwa, Anju
    Bobba, Kondapa
    Dhrona, Suchi
    Fontaine, Shaun
    Beckford-Vera, Denis
    Fong, Cyril
    Wilson, David
    Seo, Youngho
    Santi, Daniel
    VanBrocklin, Henry
    Flavell, Robert
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S189 - S190
  • [42] Polycaprolactone-based Nanocarriers Containing 5-fluorouracil as a Therapeutic Guided Drug Delivery Approach for Enhancing Anticancer Activity
    Mohammadian, Samaneh
    Khazaei, Majid
    Maghami, Parvaneh
    Avan, Amir
    Rezaei, Majid
    CURRENT CANCER DRUG TARGETS, 2023, 23 (07) : 524 - 533
  • [43] Biopolymeric nanoparticles based effective delivery of bioactive compounds toward the sustainable development of anticancerous therapeutics
    Pathak, Neelam
    Singh, Pankaj
    Singh, Pradeep Kumar
    Sharma, Swati
    Singh, Rajat Pratap
    Gupta, Anmol
    Mishra, Richa
    Mishra, Vivek Kumar
    Tripathi, Manikant
    FRONTIERS IN NUTRITION, 2022, 9
  • [44] Biotin-Tagged Polysaccharide Vesicular Nanocarriers for Receptor-Mediated Anticancer Drug Delivery in Cancer Cells
    Deshpande, Nilesh Umakant
    Jayakannan, Manickam
    BIOMACROMOLECULES, 2018, 19 (08) : 3572 - 3585
  • [45] Anticancer Drug Delivery for Tumor Targeting and Therapy
    Kim, Yu Jin
    Park, Il-Kyu
    Kim, Jin Soo
    Hwang, Joon
    Chung, Eui-Sik
    Huh, Kang Moo
    Lee, Yong-kyu
    2009 4TH IEEE INTERNATIONAL CONFERENCE ON NANO/MICRO ENGINEERED AND MOLECULAR SYSTEMS, VOLS 1 AND 2, 2009, : 919 - +
  • [46] Cubosomes: An Emerging and Promising Drug Delivery System for Enhancing Cancer Therapy
    Singh, Smita
    Sachan, Kapil
    Verma, Suryakant
    Singh, Nidhi
    Singh, Pranjal Kumar
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024, 25 (06) : 757 - 771
  • [47] Assessment of Drug Flow Rate in Skin Cancer Therapy for Enhancing the Drug Delivery System
    Thanaraj, Mrunalini
    Rathanasamy, Rajasekar
    Jeganathan, Prakash M.
    ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2020, 92 (03): : 1 - 16
  • [48] Transferrin-Conjugated Nanocarriers as Active-Targeted Drug Delivery Platforms for Cancer Therapy
    Nogueira-Librelotto, Daniele R.
    Codevilla, Cristiane F.
    Farooqi, Ammad
    Rolim, Clarice M. B.
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (03) : 454 - 466
  • [49] Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy
    Saravanakumar, Kandasamy
    Hu, Xiaowen
    Ali, Davoodbasha M.
    Wang, Myeong-Hyeon
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (24) : 2609 - 2625
  • [50] Recent advances in emerging pectin-derived nanocarriers for controlled delivery of bioactive compounds
    Huang, Meigui
    Sun, Yan
    Tan, Chen
    FOOD HYDROCOLLOIDS, 2023, 140